OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes.
Saved in:
| Title: | OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. |
|---|---|
| Authors: | Field LL; Department of Medical Genetics, University of British Columbia, Vancouver, Canada. llfield@interchange.ubc.ca, Bonnevie-Nielsen V, Pociot F, Lu S, Nielsen TB, Beck-Nielsen H |
| Source: | Diabetes [Diabetes] 2005 May; Vol. 54 (5), pp. 1588-91. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print Cited Medium: Print ISSN: 0012-1797 (Print) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 0012-1797 |
|---|---|
| DOI: | 10.2337/diabetes.54.5.1588 |
